GSK 690693
Tocris Bioscience, part of Bio-Techne | Catalog # 4144
Akt kinase inhibitor. Antitumor
Key Product Details
Description
Akt kinase inhibitor. Antitumor
Product Description
GSK 690693 is an ATP-competitive pan-Akt kinase inhibitor (IC50 values are 2, 13 and 9 nM of Akt1, 2 and 3 respectively). Also exhibits some inhibition for AMPK, PKA and PAK and PKC isoforms (IC50 < 100 nM). Displays antiproliferative and apoptotic effects in tumor cell lines.Licensing Information
Sold for research purposes only under agreement from GlaxoSmithKlineProduct Specifications
Molecular Weight
425.48
Formula
C21H27N7O3
Storage
Store at -20°C
Purity
≥98% (HPLC)
Chemical Name
4-[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(3S)-3-piperidinylmethoxy)-1H-imidazo[4,5-c]pyridin-4-yl]-2-methyl-3-butyn-2-ol
CAS Number
937174-76-0
PubChem ID
90488916
InChI Key
WONPMIMNXYCXKK-AWEZNQCLSA-N
SMILES
NC1=NON=C1C(N3CC)=NC2=C3C(CO[C@@H]4CNCCC4)=CN=C2C#CC(C)(C)O
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 21.27 | 50 |
Preparing Stock Solutions
for GSK 690693
The following data is based on the product molecular weight 425.48
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.5 mM | 4.70 mL | 23.50 mL | 47.01 mL |
| 2.5 mM | 0.94 mL | 4.70 mL | 9.40 mL |
| 5 mM | 0.47 mL | 2.35 mL | 4.70 mL |
| 25 mM | 0.09 mL | 0.47 mL | 0.94 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Rhodes Characterization of an Akt inhibitor with potent pharmacodynamic and antitumor activity. Cancer Res. 2008 PMID: 18381444
- Heerding Identification of 4-[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{(3S)-3-piperidinylmethoxyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl]-2-methyl-3-butyn-2-ol (GSK690693), a novel inhibitor of AKT kinase. J.Med.Chem. 2008 PMID: 18800763
Product Specific Notices for GSK 690693
For research use only
Loading...
Loading...
Loading...